• search
Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Genetic Toxicology Studies and Services Genetic Toxicology Studies and Services

Genetic Toxicology Studies and Services

We are committed to provide rapid and solution-driven genetic toxicology services to the clients.

We characterize the potential genotoxicity of compounds using various test and assays:

In vivo micronucleus test Chromosomal aberration test Traditional Ames assay

The in vivo micronucleus assay (in vivo MNT) is a reliable and commonly-employed test to meet the regulatory requirements while submitting IND, to screen the compounds (such as chemicals, impurities, pesticides, insecticides, food and feed additives) for their clastogenic potential in bone marrow of rodents (rats/mice) and as a component of exposure-based risk assessment. This assay plays a vital role in adding weight of evidence in the hazardous measurement of any chemical and quantitative risk assessments.

The Chromosomal Aberration Test (CAT) is routinely employed as part of NPD and to meet regulatory expectation to screen the compounds (such as chemicals, impurities, pesticides, insecticides, food and feed additives) for their clastogenic potential to cells (human blood lymphocytes or mammalian cell lines in culture) by evaluating the development gene/chromosome damage in the form of structural aberrations at chromosome level.

Ames test is a rapid and reliable bacterial assay used for evaluating a chemical's potential genotoxicity by measuring its ability to induce reverse mutations at selected loci of modified Salmonella and E. coli bacterial strains. These strains have various mutations and are not capable of synthesizing an essential amino acid, either histidine (Salmonella) or tryptophan (E. coli), so they can only grow in the culture medium that is supplemented with that amino acid. Once the bacteria are exposed to a mutagen, mutation(s) occur that could restore/reverse the ability of the bacteria to synthesize the amino acid and to continue growth even after depletion of traces of provided amino acid in the agar. Relevant mutations involve substitution of individual base pairs or frameshift mutations caused by addition or deletion of a stretch of DNA. The Ames test can be carried out in the presence and absence of a metabolizing system to identify potential mutagenicity by the parent compound and/or its metabolites.

Speak to our experts

In vivo Micronucleus Test

Young and healthy rats/mice are exposed to the compound of interest at different concentrations derived from dose range finding study. Post treatment, animals will be euthanized and femurs are collected. Bone marrow cells from femurs are isolated and fixed on slides and then staining is performed. Four thousand polychromatic erythrocytes per each animal will be screened to measure the frequency of micronulated - polychromatic erythrocytes.

Positive results demonstrate an increase in the frequency of micronucleated polychromatic erythrocytes in treated animals which is an indication of induced chromosome damage. Increase can be statistically significant and/or dose-dependent.

Chromosomal Aberration Test

Cells in cultures are exposed to the compound of interest at different concentrations for shorter duration (3-6 hours) and continuously (1.5 cell cycle time) till harvesting. In shorter duration exposure, testing will be performed by supplying liver metabolizing enzymes to evaluate by-products of compound and in other hand absence of metabolism support in shorter and continuous exposures to evaluate direct compound activity.

Positive results demonstrate an increase in the percentage of structural aberrations in comparison with concurrent controls. Increase can be statistically significant and/or dose-dependent.

Traditional Ames Assay

Mini Ames

For repeated and multiple screenings, we provide Mini Ames Test by using TA98/TA100/E. coli wp2 strains; Non-GLP screening assay to evaluate the multiple compounds in each step especially where test items are accessible at very less quantity.

Ames-Fluctuation assay

We make the screening much more convenient by adding the one more high-throughput fluctuation assay. The extra added advantage in this service is which requires a very small amount of compound i.e. less than 50 mg. This is a 384-well plate method where Salmonella strains, TA98, TA100, TA1535, and TA1537 will be tested by exposing the test item in the exposure liquid purple color media and mutations indicated as yellow color colonies after incubation.

Why Aurigene Pharmaceutical Services?

Quick turnaround time

Extensive experience in the genetic toxicology studies

Team of expert analytical and toxicology scientists

State-of-the-art facilities

Virtual Tour

 

Contact Us

Country
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
“Bathtub Chemistry” - Necessity and Aspects of Process Research

MAY 19, 2023

“Bathtub Chemistry” - Necessity and Aspects of Process Research

Medicine is an essential part of our life. Since ancient time human civilization has been tirelessly engaged to understand the cause and effect of a disease. Sometimes they win and many times they loss. But the story of their curiosity and enthusiasm is a never damping process. On the contrary it increases day by day, year after year.    &nbsp...

Read More

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

 Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contract development and manufacturing organizations (CDMOs) for collaborations as they seek more adaptable capacity and c...

Read More

How the re-designed synthesis of a complex carbohydrate can reduce cycle time

Project challenge: Complex carbohydrate chemistry involving a linear sequence of 10 chemical transformations, unstable intermediates and column chromatographic purications. Solution design: Process research and optimization was performed to develop a robust and scalable process which was implemented on commercial scale. Telescoping of reactions reduced the number...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug

2023

Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All
  • High-Potent Manufacturing

    Capabilities Video

  • CADD & Informatics

    Team Leaders Videos

  • Early Phase Development and Pilot Facility

    Team Leaders Videos

  • Custom peptide synthesis

    Team Leaders Videos

View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack